Skip to main content
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Cited by
    This chapter has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Rios, Elisabete and de Beça, Francisco Ferro 2017. Pathology of the Gastrointestinal Tract. p. 483.

  • Print publication year: 2008
  • Online publication date: January 2010


The underlying pathological mechanism of thrombotic thrombocytopenic purpura (TTP) is the presence of microvascular thrombi that partially occlude the vascular lumins with overlying proliferative endothelial cells. Coombs-negative hemolytic anemia and severe thrombocytopenia owing to platelet clumping in the microcirculation are the most outstanding laboratory abnormalities. Classically, TTP has been recognized by the pentad of microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, fever, and renal involvement, though only 20 to 40 percentage of patients will manifest the classic pentad. TTP remains a life-threatening disease the mortality rate of which may be as high as 90 percentage when untreated. Diagnosis is mainly based on hematological findings and a broad variety of neurological abnormalities, including ischemic or, less often, hemorrhagic stroke. Plasma exchange (PE) is currently the mainstay of treatment; however, rapid advances in the understanding of TTP pathophysiology may offer more specific and effective therapies in the near future.
Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Uncommon Causes of Stroke
  • Online ISBN: 9780511544897
  • Book DOI:
Please enter your name
Please enter a valid email address
Who would you like to send this to *


Aydogan, L., Alkan, G., Karadogan, K. S., et al. 2005. Painful penile ulceration in a patient with malignant atrophic papulosis. J Eur Acad Dermatol Venereol, 5, 612–6.
Ball, E., Newburger, A., and Ackerman, A. B. 2003. Degos’ disease: a distinctive pattern of disease, chiefly of lupus erythematous, and not a specific disease per se. Am J Dermatopathol, 25, 308–20.
Bjorck, S., Johansson, S. L., and Aurell, M. 1984. Acute renal failure caused by a rapidly progressive arterio-occlusive syndrome – Kohlmeier-Degos’ disease? Scand J Urol Nephrol, 18, 343–6.
Burrow, J. N., Blumbergs, P. C., Iyer, P. V., and Hallpike, J. F. 1991. Kohlmeier-Degos disease: a multisystem vasculopathy with progressive cerebral infarction. Aust N Z J Med, 21, 49–51.
Caviness, V. S. Jr., Sagar, P., Israel, E. J., et al. 2006. Case 38–2006: a 5-year old boy with headache and abdominal pain. N Engl J Med, 355, 2575–84.
Degos, R. 1979. Malignant atrophic papulosis. Br J Dermatol, 100, 21–35.
Degos, R., Delort, J., and Tricot, R. 1942. Dermatite papulosquameuse atrophiante. Bulletin Societe Francais Dermatologie et Syphilligraphie, 49, 148–50.
Demitsu, T., Nakajima, K., Okayuma, R., and Tadaki, T. 1992. Malignant atrophic papulosis (Degos’ syndrome). Int J Dermatol, 31, 99–102.
Drucker, C. R. 1990. Malignant atrophic papulosis: response to antiplatelet therapy. Dermatologica, 180, 90–2.
Feuerman, E. J. 1966. Papulosis atrophicans maligna Degos with microaneurysms of the conjunctiva. Arch Dermatol, 94, 440–5.
Habbema, L., Kisch, L. S., and Starink, T.,M. 1986. Familial malignant atrophic papulosis (Degos’ disease) additional evidence for heredity and a benign course. Br J Dermatol, 114, 134–5.
Horner, F. A., Myers, G. J., Stumpf, D. A., Oseroff, B. J., and Choi, B. H. 1976. Malignant atrophic papulosis (Kholmeier-Degos disease) in childhood. Neurology, 26, 317–21.
Howard, R. O., and Nishida, S. 1969. A case of Degos’ disease with electron microscopic findings. Trans Am Acad Ophthalmol Otolaryngol, 73, 1097–112.
Kanekura, T., Uchino, Y., and Kanzaki, T. 2003. A case of malignant atrophic papulosis successfully treated with nicotine patches. Br J Dermatol, 149, 655–80.
Kocheril, S. V., Blaivas, M., Appleton, B. E., McCune, W. J., and Ike, R. W. 2004. Degos’ disease mimicking vasculitis. Arthritis Rheum Arthritis Care Res, 51, 498–500.
Kohlmeier, W. 1941a. Multiple Hautnekrausen bei thrombangiitis obliterans. Archiv Klinik Experimentale Dermatologie, 181, 783–92.
Kohlmeier, W. 1941b. Bulletin Société Francais. Dermatologie et Syphiligraphie, 49, 148–50.
Label, L. S., Tandan, R., and Albers, J. W. 1983. Myelomalacia and hypoglycorrhachia in malignant atrophic papulosis. Neurology, 33, 936–9.
Lee, D. A., Su, W. P., and Liesegant, T. J. 1984. Ophthalmic changes of Degos’ disease (malignant atrophic papulosis). Ophthalmology, 91, 295–9.
Magnnat, G., Kerwin, K. S., and Gabriel, D. A. 1989. The clinical manifestations of Degos syndrome. Arch Pathol Lab Med, 113, 354–62.
Matsuura, F., Makino, K., Fukushima, T., et al. 2006. Optic nerve and spinal cord manifestations of malignant atrophic papulosis (Degos disease). J Neurol Neurosurg Psychiatry, 77, 260–2.
Mauad, T., DeFatima Lopes Calvo Tiberio, I., Baba, E., et al. 1996. Malignant atrophic papulosis (Degos’ disease) with extensive cardiopulmonary involvement. Histopathology, 28, 84–6.
McFarland, H. R., Wood, W. G., Drowns, B. V., and Meneses, A. C. O. 1978. Papulosis atrophicans,maligna (Kohlmeier-Degos disease): a disseminated occlusive vasculopathy. Ann Neurol, 3, 388–92.
Molenaar, W. M., Rosman, J. B., Donker, A. J., and Houthoff, H. J. 1987. The pathology and pathogenesis of malignant atrophic papulosis (Degos’ disease). Pathol Res Pract, 182, 98–106.
Muller, S. A., and Landry, M. 1976. Malignant atrophic papulosis (Degos’ disease). Arch Dermatol, 112, 357–63.
Pallesen, R. M. 1979. Malignant atrophic papulosis – Degos’ syndrome. Acta Chir Scand, 145, 279–83.
Paramo, J. A., Rocha, E., Cuesta, B., et al. 1985. Fibrinolysis in Degos’ disease. Thromb Haemost, 54, 730.
Roegnik, H. H., and Farmer, R. G. 1968. Degos’ disease (malignant papulosis): report of three cases with clues to etiology. J Am Acad Dermatol, 206, 1508–14.
Sotrel, A., Lacson, A. G., and Huff, K. 1983. Childhood Kohlmeier-Degos disease with atypica skin lesions. Neurology, 33, 1146–51.
Stahl, D., Thomsen, K., and Hou-Jensen, K. 1978. Malignant atrophic papulosis. Treatment with aspirin and dipyridamole. Arch Dermatol, 114, 1687–9.
Strole, W. E. Jr., Wallace, H., Clark, M. D. Jr., and Isselbacher, K. J. 1967. Progressive arterial occlusive disease (Kohlmeier-Degos). A frequently fatal cuteneosystemic disorder. N Engl J Med, 276, 195–201.
Su, W. P., Schroeter, A. L., Lee, D. A., Hsu, T., and Muller, S. A. 1985. Clinical and histological findings in Degos’ syndrome (malignant atrophic papulosis). Cutis, 35, 131–8.
Subbiah, P., Wijdicks, E., Muenter, M., et al. 1996. Skin lesion with fatal neurological outcome (Degos’ disease). Neurology, 46, 636–40.
Tribble, K., Archer, M. E., Jorizzo, J. L., et al. 1986. Malignant atrophic papulosis: absence of circulating immune complexes or vasculitis. J Am Acad Dermatol, 15, 365–9.
Tsao, H., Busam, K., Barnhill, R. L., and Haynes, H. A. 1997. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol, 36, 317–9.
Vazquez-Doval, F. J., Ruiz de Erenchun, F., Paramo, J. A., and Quintanilla, E. 1993. Malignant atrophic papulosis. A report of two cases with altered fibrinolysis and platelet function. Clin Exp Dermatol, 5, 441–4.
Yoshikawa, H., Maruta, T., Yokoji, H., et al. 1996. Degos’ disease: radiological and immunological aspects. Acta Neurol Scand, 94, 353–6.
Zamiri, M., Jarrett, P., and Snow, J. 2005. Benign cutaneous Degos disease. Int J Dermatol, 44, 654–6.